Endoscopic recurrence of esophageal varices is associated with the specific EUS abnormalities: severe peri-esophageal collateral veins and large perforating veins
A. Irisawa et al., Endoscopic recurrence of esophageal varices is associated with the specific EUS abnormalities: severe peri-esophageal collateral veins and large perforating veins, GASTROIN EN, 53(1), 2001, pp. 77-84
Background: Endoscopic ultrasonography (EUS) with a 20 MHz ultrasound (US)
catheter probe can clearly demonstrate esophageal collateral veins. The pre
sence of large peri-esophageal collateral veins has been correlated with la
rge esophageal varices in patients with portal hypertension. The correlatio
n between the size of esophageal collateral veins and endoscopic recurrence
of esophageal varices in patients with portal hypertension who had undergo
ne endoscopic injection sclerotherapy was investigated. Furthermore, whethe
r EUS findings could predict the variceal recurrence was retrospectively st
udied.
Methods: Thirty-eight patients who had undergone endoscopic injection scler
otherapy were examined every 3 to 4 months with endoscopy and US catheter p
robe for a period of 2 years. Recurrence of esophageal varices was determin
ed by endoscopic findings of either new varix formation or appearance of re
d color sign. Esophageal collateral veins were identified by US catheter pr
obe As peri-esophageal collateral veins (adjacent to the esophageal wall) a
nd para-esophageal collateral veins (separated from the esophageal wall) al
ong with perforating veins; and they were graded as severe and mild type by
US catheter probe.
Result. Ten of the 38 patients (26.3%) had endoscopic recurrence at a mean
of 10.9 months after endoscopic injection sclerotherapy. In patients with e
ndoscopic recurrences, EUS findings included a significantly (p < 0.001) hi
gher incidence of severe type peri-esophageal collateral veins, a significa
ntly larger number of perforating veins (p < 0.001) and a significantly lar
ger diameter of perforating veins (p < 0.001) compared with patients withou
t recurrence (8 of 10, 80% vs. 2 of 28, 7.1%; 1.30 vs. 0.21; 2.00 vs. 0.32
mm, respectively). The presence of veins at the esophagogastric junction di
d not correlate with recurrence.
Conclusion: Severe type peri-esophageal collateral veins and large perforat
ing veins of the esophagus detected by EUS in patients treated by endoscopi
c injection sclerotherapy signify recurrence of esophageal varices and pred
ict endoscopic recurrence of varices in subsequent months.